Giorgi L - Search Results

1

Safety review of adult clinical trial experience with lamotrigine.

Messenheimer J, Mullens EL, Giorgi L, Young F. Messenheimer J, et al. Among authors: giorgi l. Drug Saf. 1998 Apr;18(4):281-96. doi: 10.2165/00002018-199818040-00004. Drug Saf. 1998. PMID: 9565739 Review.

2

The tolerability of lamotrigine in children.

Messenheimer JA, Giorgi L, Risner ME. Messenheimer JA, et al. Among authors: giorgi l. Drug Saf. 2000 Apr;22(4):303-12. doi: 10.2165/00002018-200022040-00003. Drug Saf. 2000. PMID: 10789824 Review.

3

The tolerability of lamotrigine in elderly patients with epilepsy.

Giorgi L, Gomez G, O'Neill F, Hammer AE, Risner M. Giorgi L, et al. Drugs Aging. 2001;18(8):621-30. doi: 10.2165/00002512-200118080-00006. Drugs Aging. 2001. PMID: 11587248

4

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group.

Brodie MJ, Overstall PW, Giorgi L. Brodie MJ, et al. Among authors: giorgi l. Epilepsy Res. 1999 Oct;37(1):81-7. doi: 10.1016/s0920-1211(99)00039-x. Epilepsy Res. 1999. PMID: 10515178 Clinical Trial.

5

Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.

Giorgi L, Ritchie SY, Kirsch JM. Giorgi L, et al. Curr Med Res Opin. 2006 Oct;22(10):1867-77. doi: 10.1185/030079906X132442. Curr Med Res Opin. 2006. PMID: 17022844

6

Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.

Giorgi L, Asgharian A, Hunter B. Giorgi L, et al. Clin Ther. 2013 Sep;35(9):1321-36. doi: 10.1016/j.clinthera.2013.06.016. Epub 2013 Aug 9. Clin Ther. 2013. PMID: 23938061 Clinical Trial.

7

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Brodie MJ, Ben-Menachem E, Chouette I, Giorgi L. Brodie MJ, et al. Among authors: giorgi l. Acta Neurol Scand Suppl. 2012;(194):19-28. doi: 10.1111/ane.12016. Acta Neurol Scand Suppl. 2012. PMID: 23106522 Review.

8

Safety and tolerability of zonisamide in elderly patients with epilepsy.

Trinka E, Giorgi L, Patten A, Segieth J. Trinka E, et al. Among authors: giorgi l. Acta Neurol Scand. 2013 Dec;128(6):422-8. doi: 10.1111/ane.12162. Epub 2013 Jun 15. Acta Neurol Scand. 2013. PMID: 23773051

9

Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.

Baulac M, Patten A, Giorgi L. Baulac M, et al. Among authors: giorgi l. Epilepsia. 2014 Oct;55(10):1534-43. doi: 10.1111/epi.12749. Epub 2014 Aug 8. Epilepsia. 2014. PMID: 25109239 Free article. Clinical Trial.

10

Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

Baulac M, Brodie MJ, Patten A, Segieth J, Giorgi L. Baulac M, et al. Among authors: giorgi l. Lancet Neurol. 2012 Jul;11(7):579-88. doi: 10.1016/S1474-4422(12)70105-9. Epub 2012 Jun 8. Lancet Neurol. 2012. PMID: 22683226 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters